Cargando…
Increasing and More Commonly Refractory Mycobacterium avium Pulmonary Disease, Toronto, Ontario, Canada
In mid-2014, Public Health Ontario Laboratories identified coincident increasing Mycobacterium avium isolation and falling M. xenopi isolation in the Toronto, Ontario, Canada, area. We performed a retrospective cohort of all patients in a Toronto clinic who began treatment for either M. avium or M....
Autores principales: | Raats, Daan, Brode, Sarah K., Mehrabi, Mahtab, Marras, Theodore K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328931/ https://www.ncbi.nlm.nih.gov/pubmed/35876492 http://dx.doi.org/10.3201/eid2808.220464 |
Ejemplares similares
-
Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada
por: Aznar, Maria Luisa, et al.
Publicado: (2019) -
Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001–2013
por: Brode, Sarah K., et al.
Publicado: (2019) -
Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada
por: Brode, Sarah K., et al.
Publicado: (2017) -
Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020
por: Marras, Theodore K., et al.
Publicado: (2023) -
Ontario Veterinary College, Toronto, Canada
Publicado: (1888)